-
-
Administers Grant
-
A New Locus for Hereditary FSGS on Chromosome 2p
-
A PHASE 2, OPEN-LABEL, SINGLE-ARM, COHORT STUDY TO EVALUATE THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF SPARSENTAN TREATMENT IN PEDIATRIC SUBJECTS WITH SELECTED PROTEINURIC GLOMERULAR DISEASES (EPPIK)
-
A PHASE 2/3 TRIAL OF THE EFFICACY AND SAFETY
OF BARDOXOLONE METHYL IN PATIENTS WITH
ALPORT SYNDROME
-
A PHASE 3, OPEN-LABEL, MULTICENTER STUDY OF ALXN1210 IN CHILDREN AND ADOLESCENTS WITH ATYPICAL HEMOLYTIC-UREMIC SYNDROME (aHUS)
-
A Phase II Randomized, Placebo-Controlled, Double-Blind, Parallel Arms with Switchover, Pilot Study to Evlaluate the Efficacy and Safety of Intravenous Abatracept in Treamtne Resistant Nephrotic Syndrom (Focal Sebmental Glomerulosclerosis/Minimal Cha
-
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PARALLEL, ACTIVE-CONTROL STUDY OF THE EFFECTS OF SPARSENTAN, A DUAL ENDOTHELIN RECEPTOR AND ANGIOTENSIN RECEPTOR BLOCKER, ON RENAL OUTCOMES IN PATIENTS WITH PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
-
A study to test BI 764198 in people with a type of kidney disease called focal segmental glomerulosclerosis.
-
ACTH for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome in Children
-
Acoustic Device to Prevent Antibody Mediated Organ Transplant Failure
-
Advancing Transplantation Outcomes in Children - Mechnistic
-
An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients with Chronic Kidney Disease
-
An Observational, Multi-Center, Multi-National Long Term Follow-up Study of Atypical Hemolytic Uremic Syndrome (AHUS) Patients Treated with Eculizumab in a Prior Clinical Study
-
An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol® (doxercalciferol capsules) in Pediatric Patients with Chronic Kidney Disease Stages 3 and 4 with Secondary Hyperparathyroidism Not Yet on Dialysis
-
An observational, non-interventional, multi-center, multi-national study of patients with Atypical Hemolytic-Uremic Syndrome (aHUS Registry)
-
Defining the Landscape of HLA Risk Alleles in Primary Nephrotic Syndrome and Post Kidney Transplant Recurrence
-
Defining the role of chloride channel 5 in maintaining podocyte structure and functions
-
Functional and Phenotypic Characterization of a New FSGS Gene
-
GENETIC BASIS OF CORTICOSTEROID RESPONSE IN CHILDHOOD NEPHROTIC SYNDROME
-
Genetics of childhood nephrotic syndrome
-
H3 AFRICA KIDNEY DISEASE COHORT STUDY
-
H3 Africa Kidney Disease Research Network
-
H3Africa Kidney Disease Research Network
-
IDENTIFICATION OF VUR GENES BY COMBINED LINKAGE ANALYSIS AND EXOME SEQUENCING
-
Identification of New Non-invasive Diagnostic Tools for Vesicoureteric Reflux (VUR)
-
Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers
-
Integrative genomics of glomerular disease in the CureGN cohort
-
Nephrotic Syndrome Rare Disease Clinical Research Network III (NEPTUNE III) ("Study")
-
Novel development ofan acoustofluidic device for targeted antibody removal in pediatric organ transplan rejection
-
Pharmacokinetics of Cefepime in Children Receiving Continuous Renal Replacement Therapy
-
Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant
-
Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant
-
Single arm Study of ALXN1210 in Complement Inhibitor Treatment-Naive Adult and Adolescent Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
-
Vifor PA21 Phaslyra
-
Wake Forest Collaborative Application for an APOLLO Clinical Center